What Nova Biomedical does

Nova Biomedical is a global provider of analytical instrumentation serving biopharmaceutical, clinical, veterinary, and food-and-beverage markets. Founded in 1955 (per company history) and headquartered in Waltham, Massachusetts, the company employs 1,001-5,000 people and operates direct sales offices and distributor networks across 15+ countries spanning North America, Europe, Asia-Pacific, and South America. Following Advanced Instruments' $2.2 billion acquisition in July 2025, the two entities merged under a unified Nova Biomedical brand in October 2025 while continuing to operate as separate legal entities under Patricia Industries (Investor AB).

The company's product portfolio centers on four integrated platforms: cell culture analyzers (BioProfile FLEX2, FLEX2 Basic, FAST CDV) using proprietary MicroSensor Card technology and AI-enhanced computer vision for trypan blue exclusion; bioprocessing osmometers (OsmoTECH XT, HT, PRO) using freezing point depression technology with multi-pharmacopoeia compliance; cell line development solutions (Solentim Cell Metric X, VIPS PRO, ICON, STUDIUS data management) augmented by the July 2026 NanoCellect WOLF G2 microfluidic cell sorter acquisition; and a clinical/hospital franchise (Stat Profile Prime blood gas series, StatStrip point-of-care meters, GloCyte CSF counter, BR2 bilirubinometer) supplemented by Artel liquid handling verification systems, dairy-testing cryoscopes, and veterinary analyzers. The portfolio is delivered through direct enterprise field sales, regional distributors, and quote-based pricing for instruments paired with recurring consumables (MicroSensor Cards, reagent cartridges, calibrators) and service contracts.

Nova generates revenue through three streams: one-time hardware sales of analytical instruments (cell culture analyzers, osmometers, blood gas analyzers, cell sorters, clonal imaging systems, liquid handling verification systems); recurring consumables and reagents (MicroSensor Cards, reagent packs, calibrators) that lock in the installed base; and service and support agreements including installation, training, calibration, validation, and technical support by certified field service engineers. The company serves five primary verticals: bioprocessing (its largest segment supporting cell line development through manufacturing for biopharma customers including Pfizer, Takeda, Bristol-Myers Squibb, Janssen, and Boehringer Ingelheim); hospital/clinical diagnostics; outpatient care; veterinary; and food and beverage/dairy testing.

Name

Nova Biomedical

Legal name

Nova Biomedical

Website

https://novabiomedical.com

Company type

Private

Founded year

1955

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Nova Biomedical is a global analytical instrumentation company that develops and manufactures cell culture analyzers, bioprocessing osmometers, cell line development platforms, and clinical point-of-care and blood gas analyzers, serving biopharmaceutical, hospital, veterinary, and food-and-beverage customers worldwide through direct sales and distributors in 15+ countries.

Ownership category

akta.pro rank

Headquarters

HQ city

Waltham

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Analytical Instruments Hardware: Sale of analytical instruments including cell culture analyzers, osmometers, blood gas analyzers, cell sorters, and clonal imaging systems. Instruments are sold directly and through distributors globally.
2. Consumables and Reagents: Recurring revenue from MicroSensor Cards, calibrator cartridges, reagent packs, sample cups, and other consumables required for instrument operation. Consumables include specialized items like CDV reagent cartridges (500+ samples per pack) and sensor cards with sample/expiration limits.
3. Service and Support: Service agreements, installation, training, calibration, validation, and technical support services provided by certified field service engineers. Includes accredited calibration services and clinical validation services.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Nova Biomedical develops, manufactures, and sells advanced analytical instruments and consumables for bioprocessing, clinical diagnostics, hospital critical care, outpatient, veterinary, and food & beverage markets. The portfolio spans cell culture analyzers (BioProfile), osmometers (OsmoTECH), cell line development solutions (Solentim, NanoCellect WOLF G2), point-of-care meters (StatStrip, StatSensor), critical care blood gas analyzers (Stat Profile Prime), liquid handling verification systems (Artel), and specialty analyzers (GloCyte, BR2, dairy testing). Revenue is generated through instrument sales, recurring consumables and reagents, and service and support contracts.

Product overview

Nova Biomedical is a global provider of scientific and analytical solutions operating under a unified brand following the 2025 merger of Advanced Instruments and Nova Biomedical. The company offers a diversified portfolio of analytical instruments across bioprocessing, clinical/hospital, outpatient, veterinary, and food & beverage markets. The product portfolio centers on cell culture analyzers (BioProfile FLEX2, FLEX2 Basic, FAST CDV), bioprocessing osmometers (OsmoTECH XT, HT, PRO), and cell line development solutions (Solentim portfolio including Cell Metric X, ICON, VIPS PRO, STUDIUS, and acquired NanoCellect WOLF G2). Supporting products include point-of-care meters (StatStrip, StatSensor lines), critical care blood gas analyzers (Stat Profile Prime series), liquid handling verification systems (Artel PCS, MVS), and specialized analyzers for clinical, veterinary, and food/beverage applications. The portfolio is organized around major brands including Advanced Instruments, Anoxomat, Artel, BioProfile, GloCyte, Lactate Plus, NanoCellect, Nova Max Pro, Nova Pro, StatStrip, StatSensor, Stat Profile, and Solentim.

Differentiator

Problem solved

Functional benefit

Brands

• Advanced Instruments: Osmometry and analytical instruments brand serving bioprocessing and clinical markets
• Anoxomat
• Artel
• BioProfile
• GloCyte
• Lactate Plus
• NanoCellect
• Nova Max Pro
• Nova Pro
• StatStrip
• StatSensor
• Stat Profile
• Solentim

Products and services

• BioProfile FLEX2 Cell Culture Analyzer Automated comprehensive cell culture analyzer delivering 16-parameter testing (chemistries, gases, cell density, viability, osmolality) in approximately 4.5 minutes using MicroSensor Card technology with 275 μL sample volume. For bioprocessing and cell culture monitoring.
• BioProfile FLEX2 Basic Automated cell culture chemistry analyzer providing up to 11 tests (pH, PCO2, PO2, glucose, lactate, electrolytes, and metabolites) in under 2 minutes using 265 μL sample with maintenance-free MicroSensor Cards. Supports 21 CFR Part 11 and GMP compliance.
• Nova Primary Glucose Reference Analyzer Whole blood glucose reference analyzer using glucose oxidase electrochemistry for accurate measurement across 20-900 mg/dL range with 25 μL sample volume and automated hematocrit correction. ISO 13485 certified.
• BioProfile FAST CDV Analyzer AI-enhanced automated cell density and viability analyzer using Trypan Blue exclusion with computer vision, processing up to 45 samples per hour with automated dilutions to 140e6 cells/mL from only 100 μL sample. Designed for 21 CFR Part 11 compliance.
• OsmoTECH XT Single-Sample Micro-Osmometer Single-sample osmometer using freezing point depression technology for accurate osmolality testing (0-4000 mOsm/kg H2O) with 20 μL sample volume, supporting complex matrices and viscous samples for bioprocessing and GMP environments.
• OsmoTECH HT Automated Micro-Osmometer High-throughput plate-based osmometer in 96-well format for automated osmolality testing (0-2000 mOsm/kg H2O) with 40 μL sample volume, designed for process development and formulation screening.
• OsmoTECH PRO Multi-Sample Micro-Osmometer Walk-away multi-sample osmometer with 20-position turntable for automated osmolality testing (0-2000 mOsm/kg H2O) using 30 μL sample volume per test.
• NanoCellect WOLF G2 Gentle Cell Sorter Microfluidic-based cell sorting platform for gentle, sterile cell isolation used in cell line development, single-cell analysis, and cell therapy research applications. Acquired by Nova Biomedical in July 2026 from NanoCellect.
• Solentim Cell Metric X Clonal Imager AI-powered clonal imaging system with automated whole-well imaging for evidence of clonality, supporting IND submissions with digitalized documentation for cell line development workflows.
• Solentim ICON Protein Biologic Analyzer Protein biologic analyzer providing high-resolution automated imaging and integrated titer checking for clone selection workflows in cell line development.
• Solentim VIPS PRO Single Cell Seeder Single-cell deposition system providing high-resolution z-stack imaging and automated verification of cell arrival in wells for clonality assurance.
• STUDIUS Data Management Platform Integrated data management ecosystem connecting Solentim instruments for consistent, data-driven, accelerated cell line development workflows with 21 CFR Part 11 compliance.
• Cell Growth Supplements (InstiGRO CHO, InstiGRO HEK, InstiSHAKE CHO) Cell culture supplements including InstiGRO CHO, InstiGRO HEK, and InstiSHAKE CHO for enhanced single-cell outgrowth and clone expansion in cell line development.
• MatriClone iPSC Medium iPSC matrices including MatriClone and Clinical Manufacturing Grade Laminin for induced pluripotent stem cell culture applications.
• Artel PCS Pipette Calibration System Dual dye ratiometric photometry system for ISO 23783-2:2022 compliant pipette calibration and performance verification for laboratory liquid handling QA.
• Artel MVS Multichannel Verification System High-throughput verification system for automated liquid handlers and multichannel pipettes using dual dye ratiometric photometry technology, used by Pfizer, Janssen, Bristol-Myers Squibb, and SEKISUI XenoTech.
• ArtelWare Software Software platform for Artel liquid handling verification systems providing data management and reporting capabilities.
• StatStrip Glucose Meter Point-of-care glucose meter for hospital and clinical settings providing rapid blood glucose measurement.
• StatStrip Glucose/Ketone Meter Point-of-care meter measuring both glucose and ketone levels for metabolic monitoring in hospital and clinical settings.
• StatStrip LAC/Hb/Hct Meter Point-of-care meter for lactate, hemoglobin, and hematocrit measurement in critical care settings.
• StatStrip Lactate Meter Point-of-care lactate meter for clinical and sports medicine applications.
• Nova Pro Glucose/Ketone Meter Point-of-care analyzer for glucose and ketone measurement in hospital settings.
• StatSensor Creatinine/eGFR Meter Point-of-care meter for creatinine and estimated glomerular filtration rate (eGFR) kidney function testing.
• Stat Profile Prime Plus Blood Gas Analyzer Critical care blood gas analyzer providing comprehensive testing for pH, gases, electrolytes, metabolites, and co-oximetry for hospital and clinical lab use.
• Stat Profile Prime CCS Blood Gas Analyzer Critical care blood gas analyzer with cartridge-based configuration for clinical laboratory settings.
• Stat Profile Prime ES Blood Gas Analyzer Critical care blood gas analyzer with electrode-based configuration for extended testing capabilities.
• Stat Profile Prime ABG Blood Gas Analyzer Critical care blood gas analyzer optimized for arterial blood gas testing.
• GloCyte Automated CSF Cell Counter Automated cerebrospinal fluid cell counter for clinical laboratory analysis.
• BR2 Bilirubin Stat Analyzer Bilirubin analyzer for neonatal and clinical bilirubin testing with rapid results.
• EMS Stat Data Link Pre-hospital testing solution enabling point-of-care testing data transmission from emergency medical services.
• Allegro Outpatient Analyzer Point-of-care analyzer for outpatient testing solutions enabling rapid diagnostics during office visits.
• Nova Max Plus Glucose/Ketone Meter Consumer self-test meter for home glucose and ketone monitoring.
• Lactate Plus Sports Medicine Meter Sports medicine lactate meter for athletes and fitness monitoring applications.
• Nova Vet Glucose/Ketone Meter Veterinary point-of-care meter for animal health glucose and ketone monitoring.
• Stat Profile Prime Plus VET Blood Gas Analyzer Veterinary critical care blood gas analyzer for animal health applications.
• Anoxomat III Anaerobic Jar System Anaerobic jar system for microbiology culture applications requiring controlled atmospheric conditions.
• 4250 Single Sample Cryoscope Cryoscope for dairy testing using freezing point depression technology for milk composition analysis.
• FLM300 Fluorophos Milk Analyzer Fluorometric milk analyzer for precise milk fat analysis in dairy quality control.
• OsmoPRO Multi-Sample Micro-Osmometer (Clinical) Clinical multi-sample osmometer for automated osmolality testing in hospital and clinical laboratory environments.
• Osmo1 Single-Sample Micro-Osmometer (Clinical) Clinical single-sample osmometer for osmolality measurement in hospital and clinical laboratory settings.
• OsmoPro MAX Automated Osmometer (Clinical) Automated clinical osmometer for high-throughput osmolality testing in hospital and clinical laboratory settings.

Quantifiable outcome

• BioProfile FLEX2 delivers full 16-test profile in 4.5 minutes with 75% less sample volume compared to previous systems
• +3 more outcomes

Named customers18 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability4 records

Feature6 records

Partnerships

One partnership is on record.

• NanoCellectcoreStrategic or Co-development PartnerOn July 24, 2026, Nova Biomedical acquired certain assets from NanoCellect, a provider of microfluidic cell sorting technology. The acquisition integrates NanoCellect's WOLF G2 cell sorting platform with Nova's existing Solentim portfolio, enabling integrated cell line development workflows linking cell selection, single-cell isolation, and clone verification.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Siemens Healthineers: Provides RAPIDPoint and epoc blood gas analyzers and a broad clinical diagnostics portfolio. Comparable to Nova Biomedical in hospital and point-of-care blood gas and critical care testing.
• Agilent Technologies: Provides analytical instruments, cell analysis solutions (including the acquired ACEA xCELLigence and Biocytogen flow cytometry), and biopharma analytics. Overlap with Nova Biomedical's cell culture analytics and bioprocess analytics offerings.
• Beckman Coulter (Danaher): Major clinical diagnostics and biomedical laboratory instrument provider overlapping with Nova Biomedical's hospital blood gas, point-of-care, and clinical osmometry offerings.
• Roche Diagnostics: Global in-vitro diagnostics leader with cobas blood gas and clinical chemistry platforms that overlap with Nova Biomedical's Stat Profile Prime critical care analyzers and StatStrip point-of-care meters.
• Thermo Fisher Scientific: Through its Life Sciences Solutions and Specialty Diagnostics segments, competes with Nova Biomedical across cell culture analytics, osmometers, and clinical diagnostics. Significantly larger scale and broader portfolio.
• Bio-Rad Laboratories: Life science research and clinical diagnostics company with overlap in cell biology workflows, bioprocess analytics, and quality control reagents. Comparable mid-scale competitor to Nova Biomedical's bioprocessing portfolio.
• Abbott Point of Care: i-STAT handheld blood analyzer directly competes with Nova Biomedical's StatStrip and Nova Pro point-of-care meters and Stat Profile blood gas analyzers in hospital and outpatient settings.

Direct peers

• Cytiva (Danaher): Provides Xuri cell expansion systems, Biacore, and a broad bioprocessing workflow portfolio. Direct overlap with Nova Biomedical's BioProfile cell culture analytics and Solentim CLD instruments in serving biopharma manufacturing customers.
• Sartorius AG: Global leader in bioprocessing equipment and consumables with a strong analytics and cell line development portfolio (including BIA Separations and CellGenix). Most directly comparable to Nova Biomedical in serving cell culture, upstream bioprocessing, and CLD workflows for biopharma.

Emerging players

• Hamilton Company: Manufactures the Integra Viaflo cell culture analyzer, an automated media exchange and cell density platform directly competing with Nova Biomedical's BioProfile FLEX2 in bioprocessing labs. Smaller scale but technologically focused.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/biomedicalnova
• Facebookfacebook.com/NovaBiomedicalCorp

Compliance11 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nova Biomedical